Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125349431 | 12534943 | 1 | I | 201606 | 20160630 | 20160707 | 20160707 | EXP | ZA-AMGEN-ZAFSL2016087250 | AMGEN | 57.00 | YR | A | M | Y | 0.00000 | 20160706 | OT | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125349431 | 12534943 | 1 | PS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | Oral | 60 MG, QD | 21688 | 60 | MG | TABLET | QD | ||||||
| 125349431 | 12534943 | 2 | SS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | 21688 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125349431 | 12534943 | 1 | Hyperparathyroidism secondary |
| 125349431 | 12534943 | 2 | Chronic kidney disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125349431 | 12534943 | OT |
| 125349431 | 12534943 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125349431 | 12534943 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |